Retatrutide Results
The r/Retatrutide and r/PeptidesForWeightLoss communities are filled with personal weight-loss reports, progress photos, and outcome discussions. This page contextualizes those community reports against the controlled Phase 3 TRIUMPH trial data — so you can distinguish anecdote from evidence.
Community results are self-reported, uncontrolled, and subject to selection bias. People who achieve dramatic results are more likely to post than those who do not. TryTrutide does not endorse any sourcing method and does not verify community claims.
Common Claims — Fact-Checked
These claims appear frequently in community discussions. Each is evaluated against the best available clinical evidence.
"I lost 30 lbs in 3 months on retatrutide."
?Context NeededRapid early weight loss is plausible given the drug's mechanism, but individual results vary widely. TRIUMPH-1 showed mean 28.3% body weight loss at 80 weeks — not 3 months. Short-term reports may reflect water weight, glycogen depletion, and early appetite suppression rather than sustained fat loss.
"Retatrutide works faster than tirzepatide."
~Partially SupportedPhase 2 data suggests faster early weight loss kinetics compared to tirzepatide Phase 2 data, but no head-to-head trial exists. Community comparisons are confounded by dose differences, individual variation, and sourcing uncertainty.
"Results plateau after 6 months."
~Partially SupportedWeight loss does slow over time as the body adapts — this is consistent with TRIUMPH trial data showing the steepest loss in the first 24–36 weeks. However, TRIUMPH-1 showed continued loss through 80 weeks at the highest dose. 'Plateau' is often a dose or adherence issue, not a ceiling effect.
Evidence Summary
TRIUMPH-1 (obesity, no T2D): mean 28.3% body weight loss at 80 weeks, 12 mg dose. TRIUMPH-2 (obesity + T2D): mean 20.8% at 80 weeks. TRIUMPH-3 (obesity + CVD): mean 22.6% at 80 weeks. These are the most rigorous data available. Community reports are directionally consistent but not comparable.
Analyzed Threads
These threads were selected for editorial analysis. TryTrutide does not link to Reddit posts.
"Hit a wall at 12 weeks — is this normal or is my dose too low?"
✓SupportedClaim: Many users report a weight loss plateau around weeks 10–14, often at doses of 4–8 mg, and ask whether this is a sign they need to escalate dose or whether it is a normal physiological response.
Weight loss plateaus during GLP-1/GIP/glucagon agonist therapy are well-documented and physiologically expected. The body adapts to reduced caloric intake through metabolic adaptation (reduced resting energy expenditure) and increased appetite signaling. In the TRIUMPH-Obesity Phase 3 trial, the weight loss curve shows a characteristic deceleration after the initial rapid phase, with continued but slower loss through week 48. Dose escalation from 4 mg to 8 mg or 8 mg to 12 mg typically produces a renewed weight loss response. The community observation is consistent with the clinical data.
Reddit Observatory
26 topic categories — community claims vs. clinical evidence
Want a Physician to Review Your Eligibility?
Retatrutide is not yet FDA approved. A physician can review your health profile and discuss investigational access options.
Start Physician Review